# Peter Bastien

> Peter Bastien is a Series A investor at Hitachi Ventures backing Supply Chain Management and B2B. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Hitachi Ventures](https://shizune.co/investors/profile/hitachi-ventures)
- Location: Boston, United States
- Total investments: 4
- Last investment: Sep 2025
- Lead investor: 75%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/peter-bastien-6bb647

Peter Bastien is a Series A investor at Hitachi Ventures in Boston focused on Supply Chain Management and B2B. Pete Bastien is a Partner at Hitachi Ventures.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Supply Chain Management | 2 | 50% |
| B2B | 1 | 25% |
| Hardware | 1 | 25% |
| Robotics | 1 | 25% |
| Software | 1 | 25% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 75% |
| Seed | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 1 | 25% |
| Australia | 1 | 25% |
| United States | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Amplio | Amplio enables you to reclaim control of your supply chain by making sourcing more cost-effective. | $11.1M | Series A | Sep 24, 2025 |  |
| Provectus Algae | Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technologyand a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint.Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food and beverage, cosmetic, therapeutic, and agricultural industries. | $10.1M | Series A | Jul 22, 2025 |  |
| Provectus Algae | Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technologyand a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint.Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food and beverage, cosmetic, therapeutic, and agricultural industries. | $11.4M | Seed | Dec 14, 2021 |  |
| ClearOps | ClearOps is a firm that provides B2B supply chain software for data-driven supply chain optimisation in the machine manufacturing industry. | $10M | Series A |  |  |

4 of 4 investments shown.

## Co-investors
- [Vectr](https://shizune.co/investors/profile/vectr) — VC Fund, 2 deals together
- [Acequia Capital (AceCap)](https://shizune.co/investors/profile/acequia-capital) — VC Fund, 1 deal together
- [Alpaca VC](https://shizune.co/investors/profile/alpaca-vc) — VC Fund, 1 deal together
- [At One Ventures](https://shizune.co/investors/profile/at-one-ventures) — VC Fund, 1 deal together
- [Barkawi Group](https://shizune.co/investors/profile/barkawi-group) — VC Fund, 1 deal together
- [Construct Capital](https://shizune.co/investors/profile/construct-capital) — VC Fund, 1 deal together

## About Hitachi Ventures

VC Fund · München, Germany

Hitachi Ventures invests in innovative companies that address society’s key technological challenges in areas like IT, industrial automation (robotics, sensor technology and IoT), cloud services (data management, cybersecurity), mobility (autonomous driving, mobility services, smart infrastructure and security services), energy, smart medicine (AIfor digital imaging, smart diagnostics, remote care), smart city, smart infrastructure and more. With our first fund of USD 150M, we invest in Series A/B/C rounds in globally leading startups. From our offices in Munich, Germany, and Boston, USA, we work tirelessly to develop close ties and effective collaboration with leading innovative technology hubs and like-minded co-investors. Hitachi intends to leverage its strong position in multiple global technology markets, its expertise and network to support and promote Hitachi Ventures portfolio companies.

5 contacts available at Hitachi Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Joanna Soroka | Principal | https://shizune.co/investors/profile/joanna-soroka |
| Peter Bastien | Partner | https://shizune.co/investors/profile/peter-bastien |
| Stefan Gabriel | Founder, MD and CEO | https://shizune.co/investors/profile/stefan-gabriel-afc8 |
| Tobias Jahn | Partner | https://shizune.co/investors/profile/tobias-jahn |
| Wolfgang Seibold | Partner & CFO | https://shizune.co/investors/profile/wolfgang-seibold |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Peter Bastien invest in?

Peter Bastien invests primarily in Supply Chain Management, B2B and Hardware startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Peter Bastien last invest?

The most recent investment recorded for Peter Bastien closed in Sep 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co